Skip to main content
Clinical Trials/CTRI/2022/02/040479
CTRI/2022/02/040479
Not yet recruiting
Phase 2

RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE EFFICACY OF RALADI LEPA AND SHRUNGABERADI LEPA IN THE MANAGMENT OF DADRU KUSHTA WITH SPECIAL REFERENCE TO TINEA (CORPORIS AND CRURIS).

Dr Sachin Pawar0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Sachin Pawar
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sachin Pawar

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects of Dadru with cardinal signs and symptoms Kandu (Itching),Raga(Redness), and Pidaka (Eruption) will be selected for this study.
  • 2\.Subjects between the age group of 18 to 70 years both inclusive will be selected for
  • this study.
  • 3\.Both Male and Female (non\-pregnant, non\-lactating) gender Subjects are included in
  • 4\.Written consent showing willingness to participate in the study.

Exclusion Criteria

  • 1\.Subjects of Severe/Chronic hepatic or renal disease .
  • 2\.Subjects with known Chronic Infectious Disease, such as active Tuberculosis,
  • Hepatitis B or C, or HIV.
  • 3\.Chronicity more than 2 years.
  • 4\.Pregnant women and lactating mothers.
  • 5\.Age group below 18 and above 70 years.

Outcomes

Primary Outcomes

Not specified

Similar Trials